aluminum sulfate has been researched along with Toxoplasmosis, Cerebral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angel, SO; Cuppari, AF; Frank, FM; Goldman, A; Ledesma, B; Martin, V; Sanchez, V | 1 |
1 other study(ies) available for aluminum sulfate and Toxoplasmosis, Cerebral
| Article | Year |
|---|---|
Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Protozoan; Antigens, Protozoan; Cells, Cultured; Encephalitis; Genes, Protozoan; Immunoglobulin G; Interferon-gamma; Interleukin-10; Mice; Mice, Inbred C3H; Protozoan Proteins; Protozoan Vaccines; Recombinant Proteins; Toxoplasma; Toxoplasmosis, Animal; Toxoplasmosis, Cerebral | 2008 |